Continuous improvement of FEV(1) in severe eosinophilic asthmatics on anti-interleukin-5 therapy. Michils A, Makhoul JP, Blekic N, Haccuria A, et al. Allergy 2024 Apr 24. doi: 10.1111/all.16139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Michils A, Makhoul JP, Blekic N, Haccuria A, et al. Continuous improvement of FEV(1) in severe eosinophilic asthmatics on anti-interleukin-5 therapy. Allergy 2024 Apr 24. doi: 10.1111/all.16139.
PMID: 38659210